Nirnay Diagnostic And Research Center Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 87.50 K
as on 15-12-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 15-12-2024
- Revenue 10.19%
(FY 2020)
- Profit 38.93%
(FY 2020)
- Ebitda -25.77%
(FY 2020)
- Net Worth
- Total Assets -1.54%
(FY 2020)
About Nirnay Diagnostic And Research Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 87.50 K .
The company currently has active open charges totaling ₹4.00 M.
Pravin Salunkhe, Suresh Vasaikar, Rajesh Agrawal, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85100MH2008PTC188009
- Company No.
188009
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Dhule, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nirnay Diagnostic And Research Center?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravin Salunkhe  | Director | 06-Nov-2008 | Current |
| Suresh Vasaikar | Director | 06-Nov-2008 | Current |
| Rajesh Agrawal | Director | 06-Nov-2008 | Current |
| Prashant Patil | Director | 06-Nov-2008 | Current |
| Pramod Kulkarni | Director | 01-Apr-2009 | Current |
| Shreeram Bhatwal | Director | 01-Apr-2009 | Current |
Financial Performance and Corporate Structure Insights of Nirnay Diagnostic And Research Center.
Nirnay Diagnostic And Research Center Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 10.19% increase. The company also saw a substantial improvement in profitability, with a 38.93% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirnay Diagnostic And Research Center?
In 2017, Nirnay Diagnostic And Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Seva Super Speciality And Critical Care Center Private LimitedActive 14 years 6 monthsRajesh Agrawal and Prashant Patil are mutual person
- Aastha Intensive Care Centre Private LimitedActive 20 years 9 months
Pramod Kulkarni and Shreeram Bhatwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Dhue Main Branch Creation Date: 23 Sep 2013 | ₹4.00 M | Open |
How Many Employees Work at Nirnay Diagnostic And Research Center?
Unlock and access historical data on people associated with Nirnay Diagnostic And Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirnay Diagnostic And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirnay Diagnostic And Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
